This inventor holds 1 USPTO granted patent. Top assignee: Globe Biotech Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Samir Kumar: Innovator in Coronavirus Vaccine Development
Introduction
Samir Kumar is a prominent inventor based in Dacca, Bangladesh. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His innovative work focuses on combating the coronavirus and its variants.
Latest Patents
Samir Kumar holds a patent for a vaccine designed for use against coronavirus and its variants. The patent details a novel transgene that encodes essential components for vaccine production. This includes an RNA polymerase promoter, a 5' UTR, a secretory sequence, and a coronavirus spike protein component. Notably, the spike protein incorporates a variant sequence at amino acid position 614 of a native spike protein. Additionally, the patent describes a vaccine comprising the transgene or an mRNA transcript thereof. This groundbreaking work has the potential to significantly impact public health.
Career Highlights
Samir Kumar is associated with Globe Biotech Limited, where he applies his expertise in vaccine development. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Kakon Nag and Juwel Chandra Baray. Their collective efforts contribute to the advancement of innovative solutions in biotechnology.
Conclusion
Samir Kumar's work in developing a coronavirus vaccine exemplifies the critical role of inventors in addressing global health challenges. His contributions are paving the way for future advancements in vaccine technology.